Nicholas Kristof is right to call for more treatment and prevention. However, by suggesting that drug decriminalization was ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A federal commission to examine U.S. chronic disease could undercut real treatment for kids with depression, ADHD and other ...

Seeking mental health help is a significant step, but that first intake session can often feel more like paperwork than ...

It's currently in the crosshairs for broader reasons—but here's why the FDA has announced its recall and quality risk this week.

Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...

A new study shows that enhancing activity of a specific component of 'NMDA' receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...